BRPI0718131A2 - Cristal de carbamato de (s)-(+)-2-(2-clorofenil)-hidróoxi-etila - Google Patents

Cristal de carbamato de (s)-(+)-2-(2-clorofenil)-hidróoxi-etila

Info

Publication number
BRPI0718131A2
BRPI0718131A2 BRPI0718131-0A2A BRPI0718131A BRPI0718131A2 BR PI0718131 A2 BRPI0718131 A2 BR PI0718131A2 BR PI0718131 A BRPI0718131 A BR PI0718131A BR PI0718131 A2 BRPI0718131 A2 BR PI0718131A2
Authority
BR
Brazil
Prior art keywords
chlorophenyl
hydroxy
crystal
ethyl carbamate
carbamate
Prior art date
Application number
BRPI0718131-0A2A
Other languages
English (en)
Inventor
Matthew Peterson
Original Assignee
Transform Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transform Pharmaceuticals Inc filed Critical Transform Pharmaceuticals Inc
Publication of BRPI0718131A2 publication Critical patent/BRPI0718131A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Liquid Crystal Substances (AREA)
BRPI0718131-0A2A 2006-10-06 2007-10-05 Cristal de carbamato de (s)-(+)-2-(2-clorofenil)-hidróoxi-etila BRPI0718131A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82839206P 2006-10-06 2006-10-06
PCT/US2007/021502 WO2008045391A2 (en) 2006-10-06 2007-10-05 Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate

Publications (1)

Publication Number Publication Date
BRPI0718131A2 true BRPI0718131A2 (pt) 2013-11-05

Family

ID=39283405

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0718131-0A2A BRPI0718131A2 (pt) 2006-10-06 2007-10-05 Cristal de carbamato de (s)-(+)-2-(2-clorofenil)-hidróoxi-etila

Country Status (19)

Country Link
US (1) US7632963B2 (pt)
EP (1) EP2076258A4 (pt)
JP (1) JP2010505856A (pt)
KR (1) KR20090076958A (pt)
CN (1) CN101657195A (pt)
AU (1) AU2007307029A1 (pt)
BR (1) BRPI0718131A2 (pt)
CA (1) CA2665573A1 (pt)
CO (1) CO6180504A2 (pt)
CR (1) CR10764A (pt)
EA (1) EA200970355A1 (pt)
GT (1) GT200900076A (pt)
IL (1) IL198016A0 (pt)
MX (1) MX2009003755A (pt)
NI (1) NI200900050A (pt)
NO (1) NO20091771L (pt)
SV (1) SV2009003211A (pt)
WO (1) WO2008045391A2 (pt)
ZA (1) ZA200903095B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
WO2013100568A1 (en) * 2011-12-27 2013-07-04 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating stroke
US12054449B2 (en) 2021-08-05 2024-08-06 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate crystalline form and method for manufacturing the same
KR102399807B1 (ko) * 2021-08-05 2022-05-20 (주)바이오팜솔루션즈 페닐카바메이트 결정형 및 이의 제조 방법
WO2023014160A1 (ko) * 2021-08-05 2023-02-09 (주)바이오팜솔루션즈 페닐카바메이트 결정형 및 이의 제조 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
CN1176654C (zh) * 1999-09-10 2004-11-24 大日本油墨化学工业株式会社 喹啉酮衍生物制剂及其制法
CN1235579C (zh) * 2001-02-27 2006-01-11 奥索-麦克尼尔药品公司 用于预防或治疗神经变性疾病的氨基甲酸酯化合物
NZ533592A (en) * 2001-12-21 2006-05-26 Ortho Mcneil Pharm Inc Process for preparing 2-(substituted phenyl) - 2 - hydroxy-ethyl carbamates
US7772240B2 (en) 2003-08-18 2010-08-10 H. Lundbeck A/S Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
RS51269B (sr) * 2004-09-16 2010-12-31 Janssen Pharmaceutica N.V. Upotreba 2-fenil-1,2-etandiol-(di)karbamata za tretiranje epileptogeneze
US20070021500A1 (en) * 2005-07-12 2007-01-25 Twyman Roy E Methods for neuroprotection

Also Published As

Publication number Publication date
KR20090076958A (ko) 2009-07-13
IL198016A0 (en) 2009-12-24
NO20091771L (no) 2009-05-05
EP2076258A4 (en) 2011-09-28
EP2076258A2 (en) 2009-07-08
GT200900076A (es) 2010-05-18
US20080085930A1 (en) 2008-04-10
CO6180504A2 (es) 2010-07-19
CN101657195A (zh) 2010-02-24
WO2008045391A3 (en) 2008-06-12
EA200970355A1 (ru) 2009-12-30
US7632963B2 (en) 2009-12-15
CA2665573A1 (en) 2008-04-17
NI200900050A (es) 2010-02-01
WO2008045391A2 (en) 2008-04-17
CR10764A (es) 2009-09-14
MX2009003755A (es) 2009-07-10
SV2009003211A (es) 2009-11-24
AU2007307029A1 (en) 2008-04-17
ZA200903095B (en) 2010-07-28
JP2010505856A (ja) 2010-02-25

Similar Documents

Publication Publication Date Title
CY2016029I2 (el) Πρωτεϊνες συνδεσης αντιγονου προς προπρωτεϊνη κονβερτασης σουμπτιλισινης κεχιν τυπου 9(pcsk9)
DE502006003629D1 (de) Lastschaltbares gruppengetriebe
DE602005001664D1 (de) Optischer Entfernungsmesser
DE602005005030D1 (de) Stufenloses riemengetriebe
FI20055630A0 (fi) Kasvonaamio
DE502005005664D1 (de) Chronograph
DE112006003808A5 (de) Halteschlaufe
DE502005004534D1 (de) Kämmmaschine
BRPI0718131A2 (pt) Cristal de carbamato de (s)-(+)-2-(2-clorofenil)-hidróoxi-etila
DE112007002678A5 (de) Uhrengehäuse
DE502005003827D1 (de) Zahnrad
DE112005001381T5 (de) Gangschaltungssystem
BRPI0717824A2 (pt) Cristal de carbamato de (s)-(+)-2-(2-clorofenil)-2-hidróxi-etila
DK1723278T3 (da) Multiaksialt kompleks
FR2877833B1 (fr) Correcteur de lordoses
FR2908664B3 (fr) Lunettes de natation
FI20040753A0 (fi) Turvaväline
ES1064213Y (es) Gafas de natacion
ES1062437Y (es) Gafas de natacion
ITNA20060014U1 (it) Alettine bracciali per nuoto
FI20041336A0 (fi) Apuväline
ES1061605Y (es) Gafas de natacion
ES1060241Y (es) Gafas de natacion
ES1061606Y (es) Gafas de natacion
FI20050571A0 (fi) Käyttömenetelmä

Legal Events

Date Code Title Description
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 5A, 6A E 7A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A, 7A, 8A, 9A, 10A, 11A, 12A E 13A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.